AstraZeneca is conducting a study titled Chronicling the COPD Patient Journey and Change in Impact of a Single Inhaler Combination Therapy on COPD Symptoms, Quality of Life and Exacerbations Following ...

The recent clinical study update from Regeneron Pharmaceuticals and Sanofi focuses on the investigation of Itepekimab, an anti-IL-33 monoclonal antibody, to understand its effects ...

Observational and interventional studies have shown the Mediterranean diet can help reduce cardiovascular risk factors and outcomes, type 2 diabetes, overweight and obesity, and cancer risk, including ...

Prioritizing communications between patients and health care providers and increasing patient education about chronic ...

Additionally, a study published in July 2025 examined the use of methotrexate as first-line treatment for pulmonary sarcoidosis, moving away from the traditional prednisone-first approach. This ...

This September, the Pulmonary Fibrosis Foundation (PFF), will lead a nationwide campaign to raise awareness of pulmonary ...

Patients with end-stage COPD with or without pulmonary hypertension had significantly different clinical, hemodynamic and imaging characteristics from patients with mild COPD with a pulmonary vascular ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and the UCLA Palliative Care Research Center, found that many people with advanced cancer report that their ...

When faced with advanced cancer, many patients must make deeply personal decisions about their care plan. Some may pursue more aggressive treatment ...

Study of 6,694 patients finds renal dysfunction common in pulmonary hypertension and strongly linked to mortality.

No significant associations seen between treated gastroesophageal reflux disease and incidence of asthma or lung cancer.

The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but ...